Cargando…

Activation of the Interleukin-33/ST2 Pathway Exerts Deleterious Effects in Myxomatous Mitral Valve Disease

Mitral valve disease (MVD) is a frequent cause of heart failure and death worldwide, but its etiopathogenesis is not fully understood. Interleukin (IL)-33 regulates inflammation and thrombosis in the vascular endothelium and may play a role in the atherosclerotic process, but its role in mitral valv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Pena, Amaia, Ibarrola, Jaime, Navarro, Adela, Sadaba, Alba, Tiraplegui, Carolina, Garaikoetxea, Mattie, Arrieta, Vanessa, Matilla, Lara, Fernández-Celis, Amaya, Sadaba, Rafael, Alvarez, Virginia, Gainza, Alicia, Jover, Eva, López-Andrés, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956196/ https://www.ncbi.nlm.nih.gov/pubmed/33669101 http://dx.doi.org/10.3390/ijms22052310

Ejemplares similares

Beneficial Effects of Mineralocorticoid Receptor Antagonism on Myocardial Fibrosis in an Experimental Model of the Myxomatous Degeneration of the Mitral Valve
por: Ibarrola, Jaime, et al.
Publicado: (2020)

Sex-Differences in Aortic Stenosis: Mechanistic Insights and Clinical Implications
por: Matilla, Lara, et al.
Publicado: (2022)

Targeting Fatty Acid-Binding Protein 4 Improves Pathologic Features of Aortic Stenosis
por: Garaikoetxea, Mattie, et al.
Publicado: (2022)

Sex-dependent expression of neutrophil gelatinase-associated lipocalin in aortic stenosis
por: Jover, Eva, et al.
Publicado: (2022)

Characterization of the sex-specific pattern of angiogenesis and lymphangiogenesis in aortic stenosis
por: Matilla, Lara, et al.
Publicado: (2022)

Sex-specific role of galectin-3 in aortic stenosis
por: Matilla, Lara, et al.
Publicado: (2023)

Influence of diabetes mellitus on the pathological profile of aortic stenosis: a sex-based approach
por: Martín-Núñez, Ernesto, et al.
Publicado: (2023)

Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1
por: Matilla, Lara, et al.
Publicado: (2020)

Beneficial Effects of Galectin-3 Blockade in Vascular and Aortic Valve Alterations in an Experimental Pressure Overload Model
por: Ibarrola, Jaime, et al.
Publicado: (2017)

Soluble ST2 as a New Oxidative Stress and Inflammation Marker in Metabolic Syndrome
por: Roy, Ignacio, et al.
Publicado: (2023)

Aldosterone Impairs Mitochondrial Function in Human Cardiac Fibroblasts via A-Kinase Anchor Protein 12
por: Ibarrola, Jaime, et al.
Publicado: (2018)

Beneficial Effects of Mineralocorticoid Receptor Pathway Blockade against Endothelial Inflammation Induced by SARS-CoV-2 Spike Protein
por: Jover, Eva, et al.
Publicado: (2021)

Role for Galectin‐3 in Calcific Aortic Valve Stenosis
por: Sádaba, J. Rafael, et al.
Publicado: (2016)

Myxomatous degeneration of the mitral valve
por: Neto, Felippe Lazar, et al.
Publicado: (2018)

Myxomatous Mitral Valve with Prolapse and Flail Scallop
por: Fan, Jerry, et al.
Publicado: (2016)

Plasmatic Dimethylarginines in Dogs With Myxomatous Mitral Valve Disease
por: Valente, Carlotta, et al.
Publicado: (2021)

Intestinal Complication With Myxomatous Mitral Valve Diseases in Chihuahuas
por: Araki, R., et al.
Publicado: (2021)

Telotristat ethyl reverses myxomatous changes in mice mitral valves
por: Wang, Xinmei, et al.
Publicado: (2022)

The genetic consequences of dog breed formation—Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels
por: Axelsson, Erik, et al.
Publicado: (2021)

Twisting loop technique for anterior mitral cords shortening and evolution
por: Moriones, I, et al.
Publicado: (2013)

Myxomatous Mitral Valve Disease with Mitral Valve Prolapse and Mitral Annular Disjunction: Clinical and Functional Significance of the Coincidence
por: Wunderlich, Nina C., et al.
Publicado: (2021)

Mapping of the myxomatous mitral valve: The three-dimensional extension of mitral annular disjunction in surgically repaired mitral prolapse
por: Biondi, Raoul, et al.
Publicado: (2022)

Hemodynamic Effects of Protamine Infusion in Dogs with Myxomatous Mitral Valve Disease Undergoing Mitral Valvuloplasty
por: Yoshida, Tomohiko, et al.
Publicado: (2022)

The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs
por: Vezzosi, Tommaso, et al.
Publicado: (2021)

Correction: The genetic consequences of dog breed formation—Accumulation of deleterious genetic variation and fixation of mutations associated with myxomatous mitral valve disease in cavalier King Charles spaniels
por: Axelsson, Erik, et al.
Publicado: (2022)

Serum Concentrations of Leptin and Adiponectin in Dogs with Myxomatous Mitral Valve Disease
por: Kim, H.‐S., et al.
Publicado: (2016)

Review of Diagnostic and Therapeutic Approach to Canine Myxomatous Mitral Valve Disease
por: Menciotti, Giulio, et al.
Publicado: (2017)

Assessment of heart rate turbulence in dogs with myxomatous mitral valve disease
por: dos Santos, Julio P., et al.
Publicado: (2021)

Pro-Inflammatory and Immunological Profile of Dogs with Myxomatous Mitral Valve Disease
por: Piantedosi, Diego, et al.
Publicado: (2022)

Mitral annular disjunction in myxomatous mitral valve disease: a relevant abnormality recognizable by transthoracic echocardiography
por: Carmo, Pedro, et al.
Publicado: (2010)

Distinct Mitral Valve Proteomic Profiles in Rheumatic Heart Disease and Myxomatous Degeneration
por: Martins, Carlo de Oliveira, et al.
Publicado: (2014)

Contractile properties of the right atrial myofilaments in patients with myxomatous mitral valve degeneration
por: Bening, Constanze, et al.
Publicado: (2014)

Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease
por: Li, Qinghong, et al.
Publicado: (2015)

Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease
por: Borgarelli, M., et al.
Publicado: (2015)

Predictive model for the detection of pulmonary hypertension in dogs with myxomatous mitral valve disease
por: MIKAWA, Shoma, et al.
Publicado: (2014)

Genomic analysis in patients with myxomatous mitral valve prolapse: current state of knowledge
por: Gasser, S., et al.
Publicado: (2018)

Reliability of symmetric dimethylarginine in dogs with myxomatous mitral valve disease as kidney biomarker
por: Savarese, Alice, et al.
Publicado: (2018)

Left Atrial Strain at Different Stages of Myxomatous Mitral Valve Disease in Dogs
por: Nakamura, K., et al.
Publicado: (2017)

ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs
por: Keene, Bruce W., et al.
Publicado: (2019)

Prevalence and risk factors for atrial fibrillation in dogs with myxomatous mitral valve disease
por: Guglielmini, Carlo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gf7ftquk6ohtd1e0alk18qqm8u